nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—S100A12—Toll-Like Receptors Cascades—CTSL—meningioma	0.0235	0.0235	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.0212	0.0212	CbGpPWpGaD
Amlexanox—PDE4C—G alpha (s) signalling events—TSHB—meningioma	0.0203	0.0203	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.0191	0.0191	CbGpPWpGaD
Amlexanox—FGF1—FGF signaling pathway—PLAUR—meningioma	0.0186	0.0186	CbGpPWpGaD
Amlexanox—PDE4D—G alpha (s) signalling events—TSHB—meningioma	0.0177	0.0177	CbGpPWpGaD
Amlexanox—PDE4A—G alpha (s) signalling events—TSHB—meningioma	0.0168	0.0168	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—PLAU—meningioma	0.0167	0.0167	CbGpPWpGaD
Amlexanox—PDE4B—G alpha (s) signalling events—TSHB—meningioma	0.0156	0.0156	CbGpPWpGaD
Amlexanox—FGF1—Differentiation Pathway—PDGFB—meningioma	0.0148	0.0148	CbGpPWpGaD
Amlexanox—FGF1—FGF signaling pathway—PLAU—meningioma	0.0131	0.0131	CbGpPWpGaD
Amlexanox—IL3—G beta:gamma signalling through PI3Kgamma—AKT1—meningioma	0.0106	0.0106	CbGpPWpGaD
Amlexanox—IL3—IL-3 Signaling Pathway—AKT1—meningioma	0.0105	0.0105	CbGpPWpGaD
Amlexanox—IL3—GPVI-mediated activation cascade—AKT1—meningioma	0.0105	0.0105	CbGpPWpGaD
Amlexanox—IL3—G-protein beta:gamma signalling—AKT1—meningioma	0.0101	0.0101	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—PGR—meningioma	0.0101	0.0101	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—PTEN—meningioma	0.00986	0.00986	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.00973	0.00973	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.00951	0.00951	CbGpPWpGaD
Amlexanox—FGF1—Constitutive PI3K/AKT Signaling in Cancer—PDGFB—meningioma	0.00927	0.00927	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.00873	0.00873	CbGpPWpGaD
Amlexanox—IL3—Immune System—AP1B1—meningioma	0.00859	0.00859	CbGpPWpGaD
Amlexanox—FGF1—PI-3K cascade—PDGFB—meningioma	0.00835	0.00835	CbGpPWpGaD
Amlexanox—FGF1—PI3K/AKT activation—PDGFB—meningioma	0.00815	0.00815	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—PDGFB—meningioma	0.00809	0.00809	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—PDGFB—meningioma	0.0079	0.0079	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CTSL—meningioma	0.00762	0.00762	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00717	0.00717	CbGpPWpGaD
Amlexanox—S100A12—Immune System—AP1B1—meningioma	0.00688	0.00688	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—PLAUR—meningioma	0.00678	0.00678	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—TP53—meningioma	0.00673	0.00673	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—TSHB—meningioma	0.0065	0.0065	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—AP1B1—meningioma	0.00649	0.00649	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—PDGFB—meningioma	0.00624	0.00624	CbGpPWpGaD
Amlexanox—FGF1—Constitutive PI3K/AKT Signaling in Cancer—ERBB2—meningioma	0.00621	0.00621	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00611	0.00611	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—PDGFB—meningioma	0.00597	0.00597	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—PDGFB—meningioma	0.00597	0.00597	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—TSHB—meningioma	0.0059	0.0059	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—PDGFB—meningioma	0.00588	0.00588	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD34—meningioma	0.0058	0.0058	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—PDGFB—meningioma	0.00561	0.00561	CbGpPWpGaD
Amlexanox—FGF1—PI-3K cascade—ERBB2—meningioma	0.0056	0.0056	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—PDGFB—meningioma	0.00559	0.00559	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—PDGFB—meningioma	0.00556	0.00556	CbGpPWpGaD
Amlexanox—IL3—Immune System—CTSL—meningioma	0.00554	0.00554	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—PDGFB—meningioma	0.00553	0.00553	CbGpPWpGaD
Amlexanox—FGF1—PI3K/AKT activation—ERBB2—meningioma	0.00546	0.00546	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—PDGFB—meningioma	0.00545	0.00545	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—ERBB2—meningioma	0.00542	0.00542	CbGpPWpGaD
Amlexanox—FGF1—Constitutive PI3K/AKT Signaling in Cancer—PTEN—meningioma	0.0053	0.0053	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB2—meningioma	0.0053	0.0053	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—PDGFB—meningioma	0.0052	0.0052	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—PDGFB—meningioma	0.0052	0.0052	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—PDGFB—meningioma	0.0052	0.0052	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—PDGFB—meningioma	0.00516	0.00516	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—PDGFB—meningioma	0.00511	0.00511	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—PDGFB—meningioma	0.00509	0.00509	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—SMO—meningioma	0.00502	0.00502	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—PDGFB—meningioma	0.0049	0.0049	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—PDGFB—meningioma	0.00482	0.00482	CbGpPWpGaD
Amlexanox—FGF1—PI-3K cascade—PTEN—meningioma	0.00477	0.00477	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—PLAU—meningioma	0.00476	0.00476	CbGpPWpGaD
Amlexanox—FGF1—PI3K/AKT activation—PTEN—meningioma	0.00466	0.00466	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD34—meningioma	0.00465	0.00465	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—PTEN—meningioma	0.00462	0.00462	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—PDGFB—meningioma	0.00461	0.00461	CbGpPWpGaD
Amlexanox—PDE4D—TSH signaling pathway—AKT1—meningioma	0.0046	0.0046	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—meningioma	0.00452	0.00452	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CTSL—meningioma	0.00444	0.00444	CbGpPWpGaD
Amlexanox—FGF1—FGF signaling pathway—AKT1—meningioma	0.00443	0.00443	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD34—meningioma	0.00438	0.00438	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CTSL—meningioma	0.00435	0.00435	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—ERBB2—meningioma	0.00418	0.00418	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CTSL—meningioma	0.00418	0.00418	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00417	0.00417	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—TSHB—meningioma	0.00417	0.00417	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—ERBB2—meningioma	0.004	0.004	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—ERBB2—meningioma	0.00394	0.00394	CbGpPWpGaD
Amlexanox—FGF1—Immune System—AP1B1—meningioma	0.00393	0.00393	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—TSHB—meningioma	0.00378	0.00378	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—ERBB2—meningioma	0.00376	0.00376	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—ERBB2—meningioma	0.00374	0.00374	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—ERBB2—meningioma	0.00373	0.00373	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—ERBB2—meningioma	0.00371	0.00371	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—meningioma	0.00365	0.00365	CbGpPWpGaD
Amlexanox—FGF1—Disease—AP1B1—meningioma	0.00363	0.00363	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—TSHB—meningioma	0.00363	0.00363	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—PTEN—meningioma	0.00357	0.00357	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—PDGFB—meningioma	0.00355	0.00355	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—PDGFB—meningioma	0.00354	0.00354	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00352	0.00352	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—ERBB2—meningioma	0.00349	0.00349	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	0.00349	0.00349	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—ERBB2—meningioma	0.00349	0.00349	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TSHB—meningioma	0.00349	0.00349	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—ERBB2—meningioma	0.00346	0.00346	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—TSHB—meningioma	0.00345	0.00345	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—ERBB2—meningioma	0.00343	0.00343	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—PTEN—meningioma	0.00341	0.00341	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—ERBB2—meningioma	0.00341	0.00341	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—PTEN—meningioma	0.00336	0.00336	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—TSHB—meningioma	0.00329	0.00329	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00328	0.00328	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—ERBB2—meningioma	0.00323	0.00323	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—SMO—meningioma	0.00322	0.00322	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—PTEN—meningioma	0.00321	0.00321	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—TSHB—meningioma	0.00319	0.00319	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—PTEN—meningioma	0.00319	0.00319	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—PTEN—meningioma	0.00318	0.00318	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—PTEN—meningioma	0.00316	0.00316	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—TSHB—meningioma	0.00313	0.00313	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—AKT1—meningioma	0.00313	0.00313	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—PTEN—meningioma	0.00312	0.00312	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.00309	0.00309	CbGpPWpGaD
Amlexanox—FGF1—Constitutive PI3K/AKT Signaling in Cancer—AKT1—meningioma	0.00305	0.00305	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—PTEN—meningioma	0.00297	0.00297	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—PTEN—meningioma	0.00297	0.00297	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.00297	0.00297	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SMO—meningioma	0.00297	0.00297	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—PTEN—meningioma	0.00295	0.00295	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—PTEN—meningioma	0.00292	0.00292	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—PTEN—meningioma	0.00291	0.00291	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TSHB—meningioma	0.0029	0.0029	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PGR—meningioma	0.00284	0.00284	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—SMO—meningioma	0.0028	0.0028	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.0028	0.0028	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—PTEN—meningioma	0.00275	0.00275	CbGpPWpGaD
Amlexanox—FGF1—PI-3K cascade—AKT1—meningioma	0.00275	0.00275	CbGpPWpGaD
Amlexanox—FGF1—PI3K/AKT activation—AKT1—meningioma	0.00269	0.00269	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—SMO—meningioma	0.00267	0.00267	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—AKT1—meningioma	0.00266	0.00266	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD34—meningioma	0.00266	0.00266	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.00263	0.00263	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—meningioma	0.0026	0.0026	CbGpPWpGaD
Amlexanox—IL3—Immune System—PDGFB—meningioma	0.00257	0.00257	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CTSL—meningioma	0.00254	0.00254	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—SMO—meningioma	0.00247	0.00247	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—ERBB2—meningioma	0.00238	0.00238	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—ERBB2—meningioma	0.00237	0.00237	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TSHB—meningioma	0.00223	0.00223	CbGpPWpGaD
Amlexanox—FGF1—Disease—CST3—meningioma	0.00216	0.00216	CbGpPWpGaD
Amlexanox—S100A12—Immune System—PDGFB—meningioma	0.00206	0.00206	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—AKT1—meningioma	0.00206	0.00206	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—PTEN—meningioma	0.00203	0.00203	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—PTEN—meningioma	0.00202	0.00202	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—PDGFB—meningioma	0.00202	0.00202	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—AKT1—meningioma	0.00197	0.00197	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TSHB—meningioma	0.00195	0.00195	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HES1—meningioma	0.00194	0.00194	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—PDGFB—meningioma	0.00194	0.00194	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—AKT1—meningioma	0.00194	0.00194	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TP53—meningioma	0.00191	0.00191	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00191	0.00191	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SMO—meningioma	0.0019	0.0019	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TSHB—meningioma	0.00185	0.00185	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—AKT1—meningioma	0.00185	0.00185	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—AKT1—meningioma	0.00184	0.00184	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—AKT1—meningioma	0.00183	0.00183	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—AKT1—meningioma	0.00182	0.00182	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PGR—meningioma	0.00182	0.00182	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.0018	0.0018	CbGpPWpGaD
Amlexanox—IL3—Immune System—ERBB2—meningioma	0.00172	0.00172	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—AKT1—meningioma	0.00171	0.00171	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.00171	0.00171	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—AKT1—meningioma	0.00171	0.00171	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TSHB—meningioma	0.00171	0.00171	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—AKT1—meningioma	0.0017	0.0017	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—AKT1—meningioma	0.00168	0.00168	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—AKT1—meningioma	0.00168	0.00168	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PDGFB—meningioma	0.00166	0.00166	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SMO—meningioma	0.00165	0.00165	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—AKT1—meningioma	0.00162	0.00162	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00161	0.00161	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TSHB—meningioma	0.0016	0.0016	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—AKT1—meningioma	0.00159	0.00159	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PGR—meningioma	0.00159	0.00159	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SMO—meningioma	0.00157	0.00157	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.00152	0.00152	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PGR—meningioma	0.00151	0.00151	CbGpPWpGaD
Amlexanox—IL3—Immune System—PTEN—meningioma	0.00147	0.00147	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SMO—meningioma	0.00146	0.00146	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PGR—meningioma	0.0014	0.0014	CbGpPWpGaD
Amlexanox—S100A12—Immune System—ERBB2—meningioma	0.00138	0.00138	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SMO—meningioma	0.00136	0.00136	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—ERBB2—meningioma	0.00136	0.00136	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PGR—meningioma	0.0013	0.0013	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—ERBB2—meningioma	0.0013	0.0013	CbGpPWpGaD
Amlexanox—FGF1—Disease—HES1—meningioma	0.00127	0.00127	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HES1—meningioma	0.00125	0.00125	CbGpPWpGaD
Amlexanox—S100A12—Immune System—PTEN—meningioma	0.00118	0.00118	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PDGFB—meningioma	0.00118	0.00118	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—AKT1—meningioma	0.00117	0.00117	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—AKT1—meningioma	0.00117	0.00117	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—PTEN—meningioma	0.00116	0.00116	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ERBB2—meningioma	0.00111	0.00111	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—PTEN—meningioma	0.00111	0.00111	CbGpPWpGaD
Amlexanox—FGF1—Disease—PDGFB—meningioma	0.00109	0.00109	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HES1—meningioma	0.00108	0.00108	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PDGFB—meningioma	0.00107	0.00107	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HES1—meningioma	0.00103	0.00103	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—AKT1—meningioma	0.00102	0.00102	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HES1—meningioma	0.000955	0.000955	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PTEN—meningioma	0.00095	0.00095	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PDGFB—meningioma	0.000927	0.000927	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—AKT1—meningioma	0.000927	0.000927	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HES1—meningioma	0.00089	0.00089	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PDGFB—meningioma	0.000883	0.000883	CbGpPWpGaD
Amlexanox—IL3—Immune System—AKT1—meningioma	0.000847	0.000847	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PDGFB—meningioma	0.000817	0.000817	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ERBB2—meningioma	0.000789	0.000789	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PDGFB—meningioma	0.000761	0.000761	CbGpPWpGaD
Amlexanox—FGF1—Disease—ERBB2—meningioma	0.000729	0.000729	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ERBB2—meningioma	0.000714	0.000714	CbGpPWpGaD
Amlexanox—S100A12—Immune System—AKT1—meningioma	0.000679	0.000679	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PTEN—meningioma	0.000673	0.000673	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—AKT1—meningioma	0.000666	0.000666	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AKT1—meningioma	0.000654	0.000654	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—meningioma	0.000648	0.000648	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—AKT1—meningioma	0.00064	0.00064	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTEN—meningioma	0.000621	0.000621	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ERBB2—meningioma	0.000621	0.000621	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTEN—meningioma	0.000609	0.000609	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AKT1—meningioma	0.000594	0.000594	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ERBB2—meningioma	0.000592	0.000592	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AKT1—meningioma	0.000569	0.000569	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AKT1—meningioma	0.000548	0.000548	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ERBB2—meningioma	0.000547	0.000547	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AKT1—meningioma	0.000542	0.000542	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTEN—meningioma	0.00053	0.00053	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AKT1—meningioma	0.000517	0.000517	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ERBB2—meningioma	0.00051	0.00051	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTEN—meningioma	0.000504	0.000504	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AKT1—meningioma	0.000501	0.000501	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AKT1—meningioma	0.000492	0.000492	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTEN—meningioma	0.000467	0.000467	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AKT1—meningioma	0.000455	0.000455	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTEN—meningioma	0.000435	0.000435	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—meningioma	0.000415	0.000415	CbGpPWpGaD
Amlexanox—FGF1—Immune System—AKT1—meningioma	0.000388	0.000388	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—meningioma	0.000362	0.000362	CbGpPWpGaD
Amlexanox—FGF1—Disease—AKT1—meningioma	0.000358	0.000358	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AKT1—meningioma	0.000351	0.000351	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—meningioma	0.000344	0.000344	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—meningioma	0.000319	0.000319	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AKT1—meningioma	0.000305	0.000305	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—meningioma	0.000297	0.000297	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AKT1—meningioma	0.000291	0.000291	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AKT1—meningioma	0.000269	0.000269	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AKT1—meningioma	0.000251	0.000251	CbGpPWpGaD
